| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.2 |